Publication of clinical application of Panax notoginseng saponins preparation promotes healthy development in China

The clinical application of Panax notoginseng saponins preparation, initiated by Kunming Pharmaceutical Group and led by people’s Health Publishing House, was officially published. Starting from the pharmacological mechanism and characteristics of different dosage forms of Panax notoginseng saponins, the book introduces in detail the application of total saponins of Panax notoginseng in cardiovascular and cerebrovascular diseases, tumor diseases, respiratory system diseases and other diseases, with a view to enlighten clinicians and help clinicians quickly and systematically grasp the standardized use methods of Panax notoginseng saponins preparations. Panax notoginseng is widely used and has a long history in China and is one of the important traditional Chinese medicines. As early as the Ming Dynasty “fall damage Miao Fang” there is a record of “Sanqi”, the great book of Materia Medica “compendium of Materia Medica” for the first time recorded in detail the shape and smell of Panax notoginseng. The United person, the shape is slightly white and; the elderly, such as dried Rehmannia glutinosa, has stances. It has the effect of “hemostasis, dispersing blood and calming pain”. It can treat many diseases, such as injuries caused by injuries, swelling and pain of surgical sores, vomiting and bleeding in internal medicine, metrorrhagia and metrorrhagia in gynecology. Modern pharmacological studies have shown that PNS is the main chemical component and one of the main effective components of Panax notoginseng. It plays an important role in the treatment of cardiovascular and cerebrovascular diseases, respiratory diseases, urinary system diseases, digestive system diseases and so on. Panax notoginseng, as one of the ancient and valuable traditional Chinese medicine in Chinese history, has a wide range of uses and definite efficacy, and has good therapeutic effect in many diseases such as internal medicine, surgery, gynecology and so on. Through nearly 80 years’ unremitting efforts, researchers at home and abroad have isolated, extracted and identified more than 100 compounds from Panax notoginseng, and basically clarified the structure and composition of the main compounds in Panax notoginseng. Among them, Panax notoginseng saponins are the most widely used active ingredients of Panax notoginseng in clinical application. They have certain pharmacological effects in maintaining blood circulation, improving myocardial ischemia, anti arrhythmia, anti shock, sedation, improving intelligence, anti-aging, anti-oxidation and anti-tumor. < p > < p > in the 1970s, Kunming medicine was the first to isolate the intermediate of Panax notoginseng saponins; in 1983, it was the first to apply for clinical application of Panax notoginseng saponins; in 1985, it was the first to apply for the name of “Xuesaitong”; in 1986, it was the first to push Xuesaitong injection, and then developed Xuesaitong for injection Xuesaitong Soft capsules, Xuesaitong dropping pills, Xuesaitong tablets and Xuesaitong granules. With the deepening of pharmacological research on Panax notoginseng saponins, more and more people pay attention to Panax notoginseng saponins and use them in clinical treatment.